Header Logo

Connection

Peter Friedmann to Substance-Related Disorders

Back to Details
This is a "connection" page, showing publications Peter Friedmann has written about Substance-Related Disorders.
Peter Friedmann
Connection Strength
12.099
Substance-Related Disorders
  1. Peacock-Chambers E, Jurkowski BL, Kangas S, DeCoste C, McMahon TJ, Borelli JL, Feinberg E, Byatt N, Zayde A, Lowell AF, Friedmann PD. Home-based family recovery supports: Feasibility, acceptability, and adoption of training home visitors in "Mothering from the Inside Out". Infant Ment Health J. 2025 Sep; 46(5):517-535.
    View in: PubMed
    Score: 0.565
  2. Sarkar PR, Friedmann PD. Screening Adolescents for Substance Use: a Four-Step Approach for Trainees. Acad Psychiatry. 2023 10; 47(5):550-555.
    View in: PubMed
    Score: 0.503
  3. Park SE, Mosley JE, Grogan CM, Pollack HA, Humphreys K, D'Aunno T, Friedmann PD. Patient-centered care's relationship with substance use disorder treatment utilization. J Subst Abuse Treat. 2020 11; 118:108125.
    View in: PubMed
    Score: 0.409
  4. Friedmann PD, Abraham A, Evans E, Glass J, Ilgen M, Montgomery L. Editorial: COVID-19 and its impact on SUD treatment. J Subst Abuse Treat. 2020 10; 117:108091.
    View in: PubMed
    Score: 0.406
  5. Park SE, Grogan CM, Mosley JE, Humphreys K, Pollack HA, Friedmann PD. Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics. Psychiatr Serv. 2020 01 01; 71(1):35-42.
    View in: PubMed
    Score: 0.382
  6. Abraham AJ, Smith BT, Andrews CM, Bersamira CS, Grogan CM, Pollack HA, Friedmann PD. Changes in State Technical Assistance Priorities and Block Grant Funds for Addiction After ACA Implementation. Am J Public Health. 2019 06; 109(6):885-891.
    View in: PubMed
    Score: 0.371
  7. Andrews CM, Pollack HA, Abraham AJ, Grogan CM, Bersamira CS, D'Aunno T, Friedmann PD. Medicaid coverage in substance use disorder treatment after the affordable care act. J Subst Abuse Treat. 2019 07; 102:1-7.
    View in: PubMed
    Score: 0.371
  8. Andrews CM, Grogan CM, Smith BT, Abraham AJ, Pollack HA, Humphreys K, Westlake MA, Friedmann PD. Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act. Health Aff (Millwood). 2018 08; 37(8):1216-1222.
    View in: PubMed
    Score: 0.354
  9. Andrews CM, Grogan CM, Westlake MA, Abraham AJ, Pollack HA, D'Aunno TA, Friedmann PD. Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study. J Subst Abuse Treat. 2018 04; 87:50-55.
    View in: PubMed
    Score: 0.342
  10. D'Aunno T, Pollack H, Chen Q, Friedmann PD. Linkages Between Patient-centered Medical Homes and Addiction Treatment Organizations: Results From a National Survey. Med Care. 2017 04; 55(4):379-383.
    View in: PubMed
    Score: 0.322
  11. Claborn K, Becker S, Ramsey S, Rich J, Friedmann PD. Mobile technology intervention to improve care coordination between HIV and substance use treatment providers: development, training, and evaluation protocol. Addict Sci Clin Pract. 2017 03 14; 12(1):8.
    View in: PubMed
    Score: 0.321
  12. Abraham AJ, Andrews CM, Grogan CM, D'Aunno T, Humphreys KN, Pollack HA, Friedmann PD. The Affordable Care Act Transformation of Substance Use Disorder Treatment. Am J Public Health. 2017 01; 107(1):31-32.
    View in: PubMed
    Score: 0.317
  13. Welsh WN, Knudsen HK, Knight K, Ducharme L, Pankow J, Urbine T, Lindsey A, Abdel-Salam S, Wood J, Monico L, Link N, Albizu-Garcia C, Friedmann PD. Effects of an Organizational Linkage Intervention on Inter-Organizational Service Coordination Between Probation/Parole Agencies and Community Treatment Providers. Adm Policy Ment Health. 2016 Jan; 43(1):105-21.
    View in: PubMed
    Score: 0.296
  14. Hunter SB, Schwartz RP, Friedmann PD. Introduction to the Special Issue on the Studies on the Implementation of Integrated Models of Alcohol, Tobacco, and/or Drug Use Interventions and Medical Care. J Subst Abuse Treat. 2016 Jan; 60:1-5.
    View in: PubMed
    Score: 0.292
  15. Andrews C, Abraham A, Grogan CM, Pollack HA, Bersamira C, Humphreys K, Friedmann P. Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform. Health Aff (Millwood). 2015 May; 34(5):828-35.
    View in: PubMed
    Score: 0.282
  16. Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. R I Med J (2013). 2014 Oct 01; 97(10):20-4.
    View in: PubMed
    Score: 0.271
  17. Frank JW, Andrews CM, Green TC, Samuels AM, Trinh TT, Friedmann PD. Emergency department utilization among recently released prisoners: a retrospective cohort study. BMC Emerg Med. 2013 Nov 05; 13:16.
    View in: PubMed
    Score: 0.255
  18. Walley AY, Tetrault JM, Friedmann PD. Integration of substance use treatment and medical care: a special issue of JSAT. J Subst Abuse Treat. 2012 Dec; 43(4):377-81.
    View in: PubMed
    Score: 0.237
  19. Green TC, Pouget ER, Harrington M, Taxman FS, Rhodes AG, O'Connell D, Martin SS, Prendergast M, Friedmann PD. Limiting options: sex ratios, incarceration rates, and sexual risk behavior among people on probation and parole. Sex Transm Dis. 2012 Jun; 39(6):424-30.
    View in: PubMed
    Score: 0.231
  20. Friedmann PD, Green TC, Taxman FS, Harrington M, Rhodes AG, Katz E, O'Connell D, Martin SS, Frisman LK, Litt M, Burdon W, Clarke JG, Fletcher BW. Collaborative behavioral management among parolees: drug use, crime and re-arrest in the Step'n Out randomized trial. Addiction. 2012 Jun; 107(6):1099-108.
    View in: PubMed
    Score: 0.227
  21. Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O'Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus. 2012; 33(1):9-18.
    View in: PubMed
    Score: 0.224
  22. Rudes DS, Taxman FS, Portillo S, Murphy A, Rhodes A, Stitzer M, Luongo PF, Friedmann PD. Adding positive reinforcement in justice settings: acceptability and feasibility. J Subst Abuse Treat. 2012 Apr; 42(3):260-70.
    View in: PubMed
    Score: 0.220
  23. Gerstein DR, Friedmann PD. Patient satisfaction and sustained outcomes of drug abuse treatment. J Health Psychol. 2008 Apr; 13(3):388-400.
    View in: PubMed
    Score: 0.173
  24. Friedmann PD, Melnick G, Jiang L, Hamilton Z. Violent and disruptive behavior among drug-involved prisoners: relationship with psychiatric symptoms. Behav Sci Law. 2008; 26(4):389-401.
    View in: PubMed
    Score: 0.170
  25. Friedmann PD, Taxman FS, Henderson CE. Evidence-based treatment practices for drug-involved adults in the criminal justice system. J Subst Abuse Treat. 2007 Apr; 32(3):267-77.
    View in: PubMed
    Score: 0.160
  26. Friedmann PD, Alexander JA, Yey Y, Nahra T, Soliman S, Pollack HA. Duration of nonmethadone outpatient treatment: results from a national survey. Subst Abus. 2006 Sep; 27(3):47-53.
    View in: PubMed
    Score: 0.155
  27. Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006 Jan; 44(1):8-15.
    View in: PubMed
    Score: 0.148
  28. Christensen M, Boisse N, Sanchez W, Friedmann P. Teaching substance abuse screening, assessment, and brief intervention to vocational rehabilitation counselors. Subst Abus. 2005 Dec; 26(3-4):59-62.
    View in: PubMed
    Score: 0.147
  29. Mixson LS, Venkataraman A, Drumright LN, Whitney BM, Jenkins WD, Friedmann PD, Zule WA, Havens J, Ruderman SA, Stopka TJ, Korthuis PT, Pho MT, Westergaard RP, Seal DW, Go VF, Miller WC, Feinberg J, Smith G, Tsui JI, Delaney JA, Crane HM. Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative. Subst Use Addctn J. 2025 Oct; 46(4):847-858.
    View in: PubMed
    Score: 0.141
  30. Jenkins WD, Beach LB, Schneider J, Friedman SR, Pho MT, Walters S, Ezell J, Young AM, Hennessy C, Miller WC, Go VF, Sun C, Seal DW, Westergaard RP, Crane HM, Fredericksen RJ, Ruderman SA, Fletcher S, Ma J, Delaney JA, Plaisance K, Feinberg J, Smith GS, Korthuis PT, Stopka TJ, Friedmann PD, Zule W, Winer M. Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S. J Subst Use Addict Treat. 2025 Apr; 171:209629.
    View in: PubMed
    Score: 0.139
  31. Jenkins WD, Pho MT, Nance RM, Young AM, Zule W, Stopka TJ, Friedmann PD, Miller WC, Go VF, Korthuis PT, Westergaard R, Seal DW, Feinberg J, Smith GS, Crane HM, Tsui JI, Lanter T, Choudhary V. Influence of insurance type on healthcare utilization among rural people who use drugs. Drug Alcohol Depend. 2025 Apr 01; 269:112542.
    View in: PubMed
    Score: 0.138
  32. Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
    View in: PubMed
    Score: 0.137
  33. Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z. The effect of matching comprehensive services to patients' needs on drug use improvement in addiction treatment. Addiction. 2004 Aug; 99(8):962-72.
    View in: PubMed
    Score: 0.134
  34. Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z. Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs. J Behav Health Serv Res. 2004 Jan-Mar; 31(1):86-97.
    View in: PubMed
    Score: 0.129
  35. Hoover DB, Korthuis PT, Waddell EN, Foot C, Conway C, Crane HM, Friedmann PD, Go VF, Nance RM, Pho MT, Satcher MF, Sibley A, Westergaard RP, Young AM, Cook R. Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities. JAMA Netw Open. 2023 11 01; 6(11):e2342222.
    View in: PubMed
    Score: 0.127
  36. Warner EA, Walker RM, Friedmann PD. Should informed consent be required for laboratory testing for drugs of abuse in medical settings? Am J Med. 2003 Jul; 115(1):54-8.
    View in: PubMed
    Score: 0.124
  37. Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003 Jun; 38(3):887-903.
    View in: PubMed
    Score: 0.124
  38. Friedmann PD, Lemon SC, Anderson BJ, Stein MD. Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). Drug Alcohol Depend. 2003 Apr 01; 69(3):243-51.
    View in: PubMed
    Score: 0.122
  39. Sibley AL, Baker R, Levander XA, Rains A, Walters SM, Nolte K, Colston DC, Piscalko HM, Schalkoff CA, Bianchet E, Chen S, Dowd P, Jaeb M, Friedmann PD, Fredericksen RJ, Seal DW, Go VF. "I am not a junkie": Social categorization and differentiation among people who use drugs. Int J Drug Policy. 2023 04; 114:103999.
    View in: PubMed
    Score: 0.122
  40. Lowell AF, Suchman NE, Byatt N, Feinberg E, Friedmann PD, Peacock-Chambers E. Parental substance use and home visiting programs: Implementation considerations for relationship-based treatment. Infant Ment Health J. 2023 03; 44(2):166-183.
    View in: PubMed
    Score: 0.121
  41. Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003 Jan; 18(1):1-8.
    View in: PubMed
    Score: 0.120
  42. Friedmann PD, Lemon SC, Durkin EM, D'Aunno TA. Trends in comprehensive service availability in outpatient drug abuse treatment. J Subst Abuse Treat. 2003 Jan; 24(1):81-8.
    View in: PubMed
    Score: 0.120
  43. Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Community referral sources and entry of treatment-naive clients into outpatient addiction treatment. Am J Drug Alcohol Abuse. 2003; 29(1):105-15.
    View in: PubMed
    Score: 0.120
  44. Stein MD, Friedmann PD. Generalist physicians and addiction care: from turfing to sharing the turf. JAMA. 2001 Oct 10; 286(14):1764-5.
    View in: PubMed
    Score: 0.110
  45. Friedmann PD, Lemon SC, Stein MD. Transportation and retention in outpatient drug abuse treatment programs. J Subst Abuse Treat. 2001 Sep; 21(2):97-103.
    View in: PubMed
    Score: 0.109
  46. Friedmann PD, Lemon SC, Stein MD, Etheridge RM, D'Aunno TA. Linkage to medical services in the Drug Abuse Treatment Outcome Study. Med Care. 2001 Mar; 39(3):284-95.
    View in: PubMed
    Score: 0.106
  47. Friedmann PD, McCullough D, Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med. 2001 Jan 22; 161(2):248-51.
    View in: PubMed
    Score: 0.105
  48. Montgomery L, Friedmann P, Abraham A, Evans E, Glass J, Ilgen M. Editorial: Health equity in substance use disorder treatment. J Subst Abuse Treat. 2020 11; 118:108101.
    View in: PubMed
    Score: 0.102
  49. Friedmann PD, D'Aunno TA, Jin L, Alexander JA. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res. 2000 Jun; 35(2):443-65.
    View in: PubMed
    Score: 0.100
  50. Shover CL, Abraham A, D'Aunno T, Friedmann PD, Humphreys K. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs. J Subst Abuse Treat. 2019 10; 105:44-50.
    View in: PubMed
    Score: 0.095
  51. Friedmann PD, Alexander JA, Jin L, D'Aunno TA. On-site primary care and mental health services in outpatient drug abuse treatment units. J Behav Health Serv Res. 1999 Feb; 26(1):80-94.
    View in: PubMed
    Score: 0.092
  52. Friedmann PD, Saitz R, Samet JH. Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA. 1998 Apr 15; 279(15):1227-31.
    View in: PubMed
    Score: 0.087
  53. Tran Smith B, Seaton K, Andrews C, Grogan CM, Abraham A, Pollack H, Friedmann P, Humphreys K. Benefit requirements for substance use disorder treatment in state health insurance exchanges. Am J Drug Alcohol Abuse. 2018; 44(4):426-430.
    View in: PubMed
    Score: 0.085
  54. D'Aunno T, Friedmann PD, Chen Q, Wilson DM. Integration of Substance Abuse Treatment Organizations into Accountable Care Organizations: Results from a National Survey. J Health Polit Policy Law. 2015 Aug; 40(4):797-819.
    View in: PubMed
    Score: 0.071
  55. Doberczak TM, Kandall SR, Friedmann P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol. 1993 Jun; 81(6):936-40.
    View in: PubMed
    Score: 0.062
  56. Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change pharmacy practice? J Am Pharm Assoc (2003). 2013 May-Jun; 53(3):273-81.
    View in: PubMed
    Score: 0.061
  57. Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change medical practice? Pain Med. 2012 Oct; 13(10):1314-23.
    View in: PubMed
    Score: 0.058
  58. Friedmann PD, Schwartz RP. Just call it "treatment". Addict Sci Clin Pract. 2012 Jun 09; 7:10.
    View in: PubMed
    Score: 0.058
  59. Calcaterra S, Blatchford P, Friedmann PD, Binswanger IA. Psychostimulant-related deaths among former inmates. J Addict Med. 2012 Jun; 6(2):97-105.
    View in: PubMed
    Score: 0.058
  60. Hunt JJ, Cupertino AP, Garrett S, Friedmann PD, Richter KP. How is tobacco treatment provided during drug treatment? J Subst Abuse Treat. 2012 Jan; 42(1):4-15.
    View in: PubMed
    Score: 0.054
  61. Johnson JE, Friedmann PD, Green TC, Harrington M, Taxman FS. Gender and treatment response in substance use treatment-mandated parolees. J Subst Abuse Treat. 2011 Apr; 40(3):313-21.
    View in: PubMed
    Score: 0.053
  62. Sacks S, Cleland CM, Melnick G, Flynn PM, Knight K, Friedmann PD, Prendergast ML, Coen C. Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS. Behav Sci Law. 2009 Jan-Feb; 27(1):51-69.
    View in: PubMed
    Score: 0.045
  63. Rhodes AG, Taxman FS, Friedmann PD, Cropsey KL. HCV in incarcerated populations: an analysis of gender and criminality on risk. J Psychoactive Drugs. 2008 Dec; 40(4):493-501.
    View in: PubMed
    Score: 0.045
  64. Hatgis C, Friedmann PD, Wiener M. Attributions of responsibility for addiction: the effects of gender and type of substance. Subst Use Misuse. 2008; 43(5):700-8.
    View in: PubMed
    Score: 0.042
  65. Zlotnick C, Clarke JG, Friedmann PD, Roberts MB, Sacks S, Melnick G. Gender differences in comorbid disorders among offenders in prison substance abuse treatment programs. Behav Sci Law. 2008; 26(4):403-12.
    View in: PubMed
    Score: 0.042
  66. Ballard AM, Kesich Z, Crane HM, Feinberg J, Friedmann PD, Go VF, Jenkins WD, Korthuis PT, Miller WC, Pho MT, Seal DW, Smith GS, Stopka TJ, Westergaard RP, Zule WA, Young AM, Cooper HL. Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative. Drug Alcohol Depend. 2025 Jan 01; 266:112498.
    View in: PubMed
    Score: 0.034
  67. Rudolph AE, Nance RM, Bobashev G, Brook D, Akhtar W, Cook R, Cooper HL, Friedmann PD, Frost SDW, Go VF, Jenkins WD, Korthuis PT, Miller WC, Pho MT, Ruderman SA, Seal DW, Stopka TJ, Westergaard RP, Young AM, Zule WA, Tsui JI, Crane HM, Whitney BM, Delaney JAC. Evaluation of respondent-driven sampling in seven studies of people who use drugs from rural populations: findings from the Rural Opioid Initiative. BMC Med Res Methodol. 2024 Apr 23; 24(1):94.
    View in: PubMed
    Score: 0.033
  68. Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addict Behav. 2003 Sep; 28(7):1323-31.
    View in: PubMed
    Score: 0.031
  69. Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003 May; 98(5):673-84.
    View in: PubMed
    Score: 0.031
  70. Kertesz SG, Horton NJ, Friedmann PD, Saitz R, Samet JH. Slowing the revolving door: stabilization programs reduce homeless persons' substance use after detoxification. J Subst Abuse Treat. 2003 Apr; 24(3):197-207.
    View in: PubMed
    Score: 0.031
  71. Stein LAR, Bassett SS, Welsh WN, Clair-Michaud M, Abdel-Salam S, Monico L, Gallagher C, Murgo C, Yang Y, Friedmann PD, Clarke JG. Implementation Strategy Fidelity and Organizational Outcomes in a Randomized Trial: Implications for Reentry from Corrections to?Community Treatment. Subst Use Misuse. 2023; 58(3):320-330.
    View in: PubMed
    Score: 0.030
  72. Saitz R, Friedmann PD, Sullivan LM, Winter MR, Lloyd-Travaglini C, Moskowitz MA, Samet JH. Professional satisfaction experienced when caring for substance-abusing patients: faculty and resident physician perspectives. J Gen Intern Med. 2002 May; 17(5):373-6.
    View in: PubMed
    Score: 0.029
  73. Lubelczyk RA, Friedmann PD, Lemon SC, Stein MD, Gerstein DR. HIV prevention services in correctional drug treatment programs: do they change risk behaviors? AIDS Educ Prev. 2002 Apr; 14(2):117-25.
    View in: PubMed
    Score: 0.028
  74. Charuvastra A, Anderson BJ, Friedmann PD, Stein MD. Perceived addiction treatment needs among alcohol using injection drug users. J Addict Dis. 2002; 21(4):93-107.
    View in: PubMed
    Score: 0.028
  75. Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001 Jan 08; 161(1):85-91.
    View in: PubMed
    Score: 0.026
  76. Perlman DC, Perkins MP, Paone D, Kochems L, Salomon N, Friedmann P, Des Jarlais DC. "Shotgunning" as an illicit drug smoking practice. J Subst Abuse Treat. 1997 Jan-Feb; 14(1):3-9.
    View in: PubMed
    Score: 0.020
  77. Chavkin W, Paone D, Friedmann P, Wilets I. Psychiatric histories of drug using mothers: treatment implications. J Subst Abuse Treat. 1993 Sep-Oct; 10(5):445-8.
    View in: PubMed
    Score: 0.016
  78. Chavkin W, Paone D, Friedmann P, Wilets I. Reframing the debate: toward effective treatment for inner city drug-abusing mothers. Bull N Y Acad Med. 1993; 70(1):50-68.
    View in: PubMed
    Score: 0.015
  79. McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. A randomized trial of methadone initiation prior to release from incarceration. Subst Abus. 2012; 33(1):19-29.
    View in: PubMed
    Score: 0.014
  80. Gordon AJ, Fiellin DA, Friedmann PD, Gourevitch MN, Kraemer KL, Arnsten JH, Saitz R. Update in addiction medicine for the primary care clinician. J Gen Intern Med. 2008 Dec; 23(12):2112-6.
    View in: PubMed
    Score: 0.011
  81. Charuvastra A, Friedmann PD, Stein MD. Physician attitudes regarding the prescription of medical marijuana. J Addict Dis. 2005; 24(3):87-93.
    View in: PubMed
    Score: 0.009
  82. Vassilev ZP, Strauss SM, Astone JM, Friedmann PD, Des Jarlais DC. Provision of on-site medical care to patients with hepatitis C in drug treatment units. J Health Care Poor Underserved. 2004 Nov; 15(4):663-71.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.